文献速递关节外科

20,946例单髁膝关节置换的五年生存率及患者失败风险因素:德国保险数据分析

Five-Year Survival of 20,946 Unicondylar Knee Replacements and Patient Risk Factors for Failure: An Analysis of German Insurance Data.
PubMed 文献 · J Bone Joint Surg Am · 2016-01-01

该研究基于德国最大健康保险的全国住院账单数据,纳入2006至2012年间20,946例单髁膝关节置换术,分析5年假体生存率及翻修风险因素。5年生存率为87.8%(95%CI 87.3%至88.3%),翻修显著风险因素包括年轻年龄、女性、复杂性糖尿病、抑郁、肥胖(BMI≥30 kg/m2)及低手术量医院。

要点

  • 5年假体生存率为87.8%(95%CI 87.3%至88.3%)。
  • 年龄<55岁翻修风险HR 2.93(95%CI 2.48至3.46),以>74岁为参照。
  • 复杂性糖尿病HR 1.47、抑郁HR 1.29、肥胖HR 1.13均为显著翻修风险因素。

核心结论

  • 除已知风险因素外,本研究表明肥胖、抑郁和复杂性糖尿病对5年单髁膝关节置换生存率有显著负面影响。
  • 手术指征和术前患者咨询应考虑这些发现。

研究设计与样本

  • 研究使用德国最大健康保险的全国住院账单数据,识别2006年至2012年间接受单髁膝关节置换术的患者。
  • 采用以翻修为终点的Kaplan-Meier生存曲线和对数秩检验评估5年假体生存率,并使用多变量Cox回归模型确定与翻修相关的因素。
  • 分析了年龄、性别、诊断、合并症、假体固定类型和医院手术量等风险因素,计算风险比(HR)和95%置信区间(95%CI)。

主要发现

  • 研究期间共纳入20,946例单髁膝关节置换术,每年手术量从2006年的2,527例增至2012年的4,036例。
  • 患者中位年龄为64岁(四分位距56至72岁),60.4%为女性。
  • 1年翻修率从2006年的14.3%降至2011年的8.7%。
  • 5年生存率为87.8%(95%CI 87.3%至88.3%)。
  • 显著翻修风险因素(p<0.05)包括:年龄<55岁HR 2.93(95%CI 2.48至3.46)、55至64岁HR 1.86(95%CI 1.58至2.19)、65至74岁HR 1.52(95%CI 1.29至1.79),以>74岁为参照;女性HR 1.18(95%CI 1.07至1.29);复杂性糖尿病HR 1.47(95%CI 1.03至2.12);抑郁HR 1.29(95%CI 1.06至1.57);肥胖(BMI≥30 kg/m2)HR 1.13(95%CI 1.02至1.26);低手术量医院:年手术量≤10例HR 1.60(95%CI 1.39至1.84)、11至20例HR 1.47(95%CI 1.27至1.70)、21至40例HR 1.31(95%CI 1.14至1.51),以>40例为参照。

临床怎么用

  • 作者认为,手术指征和术前患者咨询应考虑肥胖、抑郁和复杂性糖尿病等风险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improvements in implant design and surgical technique of unicondylar knee arthroplasty have led to reduced revision rates, but patient selection seems to be crucial for success of such arthroplasties. The purpose of the present study was to analyze the 5-year implant survival rate of unicondylar knee replacements in Germany and to identify patient factors associated with an increased risk of revision, including >30 comorbid conditions. METHODS: Using nationwide billing data of the largest German health-care insurance for inpatient hospital treatment, we identified patients who underwent unicondylar knee arthroplasty between 2006 and 2012. Kaplan-Meier survival curves with revision as the end point and log-rank tests were used to evaluate 5-year implant survival. A multivariable Cox regression model was used to determine factors associated with revision. The risk factors of age, sex, diagnosis, comorbidities, type of implant fixation, and hospital volume were analyzed. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated. RESULTS: During the study period, a total of 20,946 unicondylar knee arthroplasties were included. The number of unicondylar knee arthroplasties per year increased during the study period from 2,527 in 2006 to 4,036 in 2012. The median patient age was 64 years (interquartile range, 56 to 72 years), and 60.4% of patients were female. During the time evaluated, the 1-year revision rate decreased from 14.3% in 2006 to 8.7% in 2011. The 5-year survival rate was 87.8% (95% CI, 87.3% to 88.3%). Significant risk factors (p < 0.05) for unicondylar knee arthroplasty revision were younger age (the HR was 2.93 [95% CI, 2.48 to 3.46] for patient age of <55 years, 1.86 [95% CI, 1.58 to 2.19] for 55 to 64 years, and 1.52 [95% CI, 1.29 to 1.79] for 65 to 74 years; patient age of >74 years was used as the reference); female sex (HR, 1.18 [95% CI, 1.07 to 1.29]); complicated diabetes (HR, 1.47 [95% CI, 1.03 to 2.12]); depression (HR, 1.29 [95% CI, 1.06 to 1.57]); obesity, defined as a body mass index of ≥30 kg/m2 (HR, 1.13 [95% CI, 1.02 to 1.26]); and low-volume hospitals, denoted as an annual hospital volume of ≤10 cases (HR, 1.60 [95% CI, 1.39 to 1.84]), 11 to 20 cases (HR, 1.47 [95% CI, 1.27 to 1.70]), and 21 to 40 cases (HR, 1.31 [95% CI, 1.14 to 1.51]) (>40 cases was used as the reference). CONCLUSIONS: Apart from known risk factors, this study showed a significant negative influence of obesity, depression, and complicated diabetes on the 5-year unicondylar knee replacement survival rate. Surgical indications and preoperative patient counseling should consider these findings. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Jeschke E, Gehrke T, Günster C, et al. Five-Year Survival of 20,946 Unicondylar Knee Replacements and Patient Risk Factors for Failure: An Analysis of German Insurance Data. J Bone Joint Surg Am. 2016. PMID: 27869619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。